Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.
IPO Date: November 1, 2003
Sector: Healthcare
Industry: Biotech
Market Cap: $8.89M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.11 | 3.45%
Avg Daily Range (30 D): $0.06 | 4.91%
Avg Daily Range (90 D): $0.06 | 4.27%
Institutional Daily Volume
Avg Daily Volume: .36M
Avg Daily Volume (30 D): 1.72M
Avg Daily Volume (90 D): .65M
Trade Size
Avg Trade Size (Sh.): 278
Avg Trade Size (Sh.) (30 D): 240
Avg Trade Size (Sh.) (90 D): 241
Institutional Trades
Total Inst.Trades: 20
Avg Inst. Trade: $1.67M
Avg Inst. Trade (30 D): $.62M
Avg Inst. Trade (90 D): $.62M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.27M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 53.4K
   
News
May 6, 2025 @ 11:00 AM
BrainStorm to Present Biomarker Insights Supportin...
Source: Prnewswire
Mar 26, 2025 @ 12:15 PM
BrainStorm Cell Therapeutics Granted Compliance Ex...
Source: Prnewswire
Feb 21, 2025 @ 6:00 PM
Cell and Gene Therapies in Rare Disorders Market t...
Source: Delveinsight
Apr 9, 2024 @ 10:05 AM
Why Biophytis Shares Are Trading Higher By Around ...
Source: Avi Kapoor
Mar 25, 2024 @ 6:44 PM
Why Landos Biopharma Shares Are Trading Higher By ...
Source: Avi Kapoor
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.45 $-.51 $-2.31
Diluted EPS $-.45 $-.51 $-2.31
Revenue $ $ $
Gross Profit $ $ $
Net Income / Loss $ -2.86M $ -2.97M $ -11.62M
Operating Income / Loss $ -3.09M $ -3.19M $ -11.69M
Cost of Revenue $ $ $
Net Cash Flow $ M $ -1.11M $ -1.11M
PE Ratio    
Splits
Oct 01, 2024:   1:15
Sep 16, 2014:   1:15
Aug 13, 2003:   2:1